166 related articles for article (PubMed ID: 26180085)
1. ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice.
Tesch GH; Ma FY; Han Y; Liles JT; Breckenridge DG; Nikolic-Paterson DJ
Diabetes; 2015 Nov; 64(11):3903-13. PubMed ID: 26180085
[TBL] [Abstract][Full Text] [Related]
2. Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in
Tesch GH; Pullen N; Jesson MI; Schlerman FJ; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1439-F1449. PubMed ID: 31566438
[TBL] [Abstract][Full Text] [Related]
3. ASK1 contributes to fibrosis and dysfunction in models of kidney disease.
Liles JT; Corkey BK; Notte GT; Budas GR; Lansdon EB; Hinojosa-Kirschenbaum F; Badal SS; Lee M; Schultz BE; Wise S; Pendem S; Graupe M; Castonguay L; Koch KA; Wong MH; Papalia GA; French DM; Sullivan T; Huntzicker EG; Ma FY; Nikolic-Paterson DJ; Altuhaifi T; Yang H; Fogo AB; Breckenridge DG
J Clin Invest; 2018 Oct; 128(10):4485-4500. PubMed ID: 30024858
[TBL] [Abstract][Full Text] [Related]
4. Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition.
Yamamoto E; Dong YF; Kataoka K; Yamashita T; Tokutomi Y; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Hypertension; 2008 Sep; 52(3):573-80. PubMed ID: 18678790
[TBL] [Abstract][Full Text] [Related]
5. DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy.
Alter ML; Ott IM; von Websky K; Tsuprykov O; Sharkovska Y; Krause-Relle K; Raila J; Henze A; Klein T; Hocher B
Kidney Blood Press Res; 2012; 36(1):119-30. PubMed ID: 23171828
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
Lim AK; Ma FY; Nikolic-Paterson DJ; Ozols E; Young MJ; Bennett BL; Friedman GC; Tesch GH
Am J Nephrol; 2011; 34(4):337-46. PubMed ID: 21876346
[TBL] [Abstract][Full Text] [Related]
7. ASK1/p38 signaling in renal tubular epithelial cells promotes renal fibrosis in the mouse obstructed kidney.
Ma FY; Tesch GH; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1263-73. PubMed ID: 25298527
[TBL] [Abstract][Full Text] [Related]
8. ASK1: a new therapeutic target for kidney disease.
Tesch GH; Ma FY; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2016 Aug; 311(2):F373-81. PubMed ID: 27226108
[TBL] [Abstract][Full Text] [Related]
9. Establishing equivalent diabetes in male and female Nos3-deficient mice results in a comparable onset of diabetic kidney injury.
Tian L; Nikolic-Paterson DJ; Tesch GH
Physiol Rep; 2019 Sep; 7(18):e14197. PubMed ID: 31535473
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of apoptosis signal-regulating kinase 1 mitigates the pathogenesis of human immunodeficiency virus-associated nephropathy.
Chen A; Xu J; Lai H; D'Agati VD; Guan TJ; Badal S; Liles J; He JC; Lee K
Nephrol Dial Transplant; 2021 Feb; 36(3):430-441. PubMed ID: 33097961
[TBL] [Abstract][Full Text] [Related]
11. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling.
Kuo CW; Shen CJ; Tung YT; Chen HL; Chen YH; Chang WH; Cheng KC; Yang SH; Chen CM
Life Sci; 2015 Aug; 135():77-86. PubMed ID: 26006040
[TBL] [Abstract][Full Text] [Related]
12. Targeting apoptosis signal-regulating kinase 1 in acute and chronic kidney disease.
Tesch GH; Ma FY; Nikolic-Paterson DJ
Anat Rec (Hoboken); 2020 Oct; 303(10):2553-2560. PubMed ID: 31971352
[TBL] [Abstract][Full Text] [Related]
13. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
[TBL] [Abstract][Full Text] [Related]
14. Homoarginine ameliorates diabetic nephropathy independent of nitric oxide synthase-3.
Wetzel MD; Stanley K; Maity S; Madesh M; Bopassa JC; Awad AS
Physiol Rep; 2021 Mar; 9(5):e14766. PubMed ID: 33713581
[TBL] [Abstract][Full Text] [Related]
15. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
16. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice.
Sakaguchi M; Isono M; Isshiki K; Sugimoto T; Koya D; Kashiwagi A
Biochem Biophys Res Commun; 2006 Feb; 340(1):296-301. PubMed ID: 16364254
[TBL] [Abstract][Full Text] [Related]
18. [Effects of lovastatin on renal function and expression of phosphorylating-p38 mitogen-activated protein kinase in experimental diabetic nephropathy in rats].
Wang LH; Duan HJ; Shi YH; Liu QJ; He N; Liu SX
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):734-7. PubMed ID: 15585148
[TBL] [Abstract][Full Text] [Related]
19. ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension.
Budas GR; Boehm M; Kojonazarov B; Viswanathan G; Tian X; Veeroju S; Novoyatleva T; Grimminger F; Hinojosa-Kirschenbaum F; Ghofrani HA; Weissmann N; Seeger W; Liles JT; Schermuly RT
Am J Respir Crit Care Med; 2018 Feb; 197(3):373-385. PubMed ID: 28910144
[TBL] [Abstract][Full Text] [Related]
20. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
